Risultati di ricerca
Deborah Moore-Lai, Director of Protein Development | Abcam. Deborah Moore-Lai joined Abcam in 2019 to lead the new Proteins Initiative, which included building out new laboratory space and recruiting a new team of scientists with skills in protein expression, purification, and assay development.
About. Senior leader with extensive experience in protein design, analytical characterization and R&D, manufacturing and operations functions. Expertise in both the reagent and drug discovery...
Deborah Moore-Lai joined Abcam in 2019 to lead the new Proteins Initiative, which included building out new laboratory space and recruiting a new team of scientists with skills in protein expression, purification, and assay development. Before joining Abcam, Deborah spent 16 years working in industry in both the reagent and therapeutic spaces.
Deborah Moore-Lai. Abcam · Department of Research and Development. Contact. Connect with experts in your field. Join ResearchGate to contact this researcher and connect with your scientific...
Senior Vice President Research & Development at Abcam. 6mo Edited. So thrilled to be the Antibody Supplier of the Year’ winner! Proud to see the many scientific achievements that were made with...
Deborah Moore-Lai. Senior Director, Protein Development Platform | Abcam Global Women's Network ERG Leader | Plenary Keynote Speaker. 2w. Wonderful opportunity to share a STEM activity with...
Deborah Moore-Lai, Abcam, USA. Proteins and reagents for cell therapy research. Timestamp: 1:01:20 - 1:19:10. Amir Horowitz, Icahn School of Medicine at Mount Sinai, USA. HLA-E and NKG2A as a novel immune checkpoint axis in bladder cancer. Timestamp: 1:20:21 - 1:55:33. Resistance to immunotherapies: Turning cold into hot - firing up the TME.
